← All stories
Markets
How Far Has Cizzle Biotechnology (LSE:CIZ) Taken Its Lung Cancer Blood Test In America?
Highlights The first phase of a United States commercial rollout has begun in selected Texas metropolitan markets. Laboratory validation was completed at a partner diagnostics facility ahead of launch. A patent allowance and newly published…
Covered by 1 outlet
All coverage · 1 article